Acadian Asset Management LLC Pyxis Oncology, Inc. Transaction History

Acadian Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$1.4 - $2.09 $2,737 - $4,085	-1,955 Reduced 14.77%	11,278 $20,000
Q3 2023 Nov 13, 2023	BUY	$1.6 - $2.78 $21,172 - $36,787	13,233 New	13,233 $26,000
Q1 2023 May 11, 2023	SELL	$1.38 - $6.0 $54,090 - $235,176	-39,196 Reduced 54.67%	32,506 $130,000
Q4 2022 Feb 14, 2023	BUY	$1.14 - $2.0 $54,559 - $95,718	47,859 Added 200.73%	71,702 $95,000
Q2 2022 Aug 09, 2022	BUY	$2.02 - $4.53 $48,162 - $108,008	23,843 New	23,843 $57,000

101

28.2M

539K

54.1K

Ticker PYXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,096,400
Market Cap $69.8M
Description
Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.